Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a peripheral vasodilator with beta-adrenergic agonist activity. It is thought to relax vascular smooth muscle, leading to vasodilation.
## Primary Indications
* Treatment of peripheral vascular disease, such as intermittent claudication.
* Management of cerebrovascular insufficiency.
* Historically used for premature labor, but this use is generally not recommended due to safety concerns and lack of efficacy compared to other agents.
## Adult Dosing
* **Intermittent Claudication/Peripheral Vascular Disease:**
* Oral: 10 mg to 20 mg three to four times daily.
* Maximum dose: Generally not to exceed 80 mg per day.
## Pediatric Dosing
* Information regarding pediatric dosing is not well-established or routinely recommended. Use with extreme caution if considered, and consult pediatric specialist literature.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment, but caution is advised due to potential for altered metabolism and excretion.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Use in patients with congenital heart disease or arrhythmias.
* Administration to patients who have recently experienced a myocardial infarction.
## Adverse Effects
* Common: Nausea, vomiting, gastric distress, dizziness, lightheadedness, weakness, blurred vision, skin rash.
* Less common: Hypotension, tachycardia, flushing, nervousness, abdominal cramps.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the hypotensive effects of antihypertensive medications.
* **Sympathomimetic agents:** May potentiate the cardiovascular effects of other sympathomimetics.
## Monitoring
* Blood pressure and heart rate, especially at the initiation of therapy or with dose increases.
* Symptoms of peripheral vascular disease (e.g., walking distance, pain).
* Signs of adverse effects.
## Clinical Pearls
* Efficacy in peripheral vascular disease is controversial, and many guidelines do not recommend its use due to limited evidence and potential adverse effects.
* The mechanism of action involves direct smooth muscle relaxation and beta-adrenergic stimulation.
* Administer oral doses with food to minimize gastric upset.
* Discontinue therapy if significant adverse effects occur.
***
*This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for definitive patient management.*
